The LCR of EBV makes Burkitt's lymphoma endemic

Trends in Microbiology

Volumn 12, Issue 11, 2004, Pages 495-499

  Niller, Hans H ^a   Salamon, Daniel ^b   Banati, Ferenc ^b   Schwarzmann, Fritz ^a   Wolf, Hans ^a   Minarovits, Janos ^b  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 2; MYC PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

APOPTOSIS; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL IMMORTALIZATION; CELL NUCLEUS; CELL STRUCTURE; CELL SURVIVAL; ENDEMIC DISEASE; EPSTEIN BARR VIRUS; HUMAN; IN VITRO STUDY; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE TRANSFORMATION; LYSIS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; REGULATOR GENE; REVIEW; T LYMPHOCYTE; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS CELL TRANSFORMATION; VIRUS GENOME; VIRUS LATENCY; VIRUS VIRULENCE;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 5644289322     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2004.09.006     Document Type: Article

References (52)

1. D.A. Thorley-Lawson Epstein-Barr virus and the B cell: that's all it takes Trends Microbiol. 4 1996 204 208
2. D.T. Rowe Epstein-Barr virus immortalization and latency Front. Biosci. 4 1999 D346 D371
3. G.C. Faulkner The ins and outs of EBV infection Trends Microbiol. 8 2000 185 189
4. E. Kieff, and A.B. Rickinson Epstein-Barr virus and its replication D.M. Knipe P.M., Howley Fields Virology 4th edn 2001 Lippincott, Williams & Wilkins 2511 2573
5. A. Rickinson, and E. Kieff Epstein-Barr virus D.M. Knipe P.M., Howley Fields Virology 2001 Lippincott, Williams & Wilkins 2575 2627
6. L.S. Young, and P.G. Murray Epstein-Barr virus and oncogenesis: from latent genes to tumours Oncogene 22 2003 5108 5121
7. R. Kuppers B cells under influence: transformation of B cells by Epstein-Barr virus Nat. Rev. Immunol. 3 2003 801 812
8. D.A. Thorley-Lawson, and A. Gross Persistence of the Epstein-Barr virus and the origins of associated lymphomas N. Engl. J. Med. 350 2004 1328 1337
9. I. Araujo Frequent expansion of Epstein-Barr virus (EBV) infected cells in germinal centres of tonsils from an area with a high incidence of EBV-associated lymphoma J. Pathol. 187 1999 326 330
10. A. Nanbo Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma EMBO J. 21 2002 954 965
11. H.H. Niller The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis Med. Sci. Monit. 9 2003 HY1 HY9
12. J. Kurth Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction Proc. Natl. Acad. Sci. U. S. A. 100 2003 4730 4735
13. C. Kiss T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines Proc. Natl. Acad. Sci. U. S. A. 100 2003 4813 4818
14. M.G. Masucci, and I. Ernberg Epstein-Barr virus: adaptation to a life within the immune system Trends Microbiol. 2 1994 125 130
15. Q. Li Locus control regions Blood 100 2002 3077 3086
16. S. Jankelevich A nuclear matrix attachment region organizes the Epstein-Barr viral plasmid in Raji cells into a single DNA domain EMBO J. 11 1992 1165 1176
17. H.H. Niller Nucleoprotein complexes and DNA 5′-ends at oriP of Epstein-Barr virus J. Biol. Chem. 270 1995 12864 12868
18. T.A. Gahn, and B. Sugden An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene J. Virol. 69 1995 2633 2636
19. B. Sugden, and N. Warren A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection J. Virol. 63 1989 2644 2649
20. R.E. White Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells J. Virol. 75 2001 11249 11252
21. B. Wensing Variant chromatin structure of the oriP region of Epstein-Barr virus and regulation of EBER1 expression by upstream sequences and oriP J. Virol. 75 2001 6235 6241
22. D. Salamon De novo DNA methylation at nonrandom founder sites 5′ from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes Biol. Chem. 381 2000 95 105
23. D. Salamon Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus J. Virol. 75 2001 2584 2596
24. H.H. Niller Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines Biol. Chem. 382 2001 1411 1419
25. M. Takacs Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes Biol. Chem. 382 2001 699 705
26. D. Salamon High-resolution methylation analysis and in vivo protein-DNA binding at the promoter of the viral oncogene LMP2A in B cell lines carrying latent Epstein-Barr virus genomes Virus Genes 27 2003 57 66
27. W. Henle Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells Science 157 1967 1064 1065
28. G. Klein In defense of the "old" Burkitt Lymphoma scenario G. Klein Advances in Viral Oncology 1987 Raven Press 207 211
29. G.M. Lenoir, and G. Bornkamm Burkitt's Lymphoma, a human cancer model for the study of the multistep dvelopment of cancer: proposal for a new scenario G. Klein Advances in Viral Oncology 1987 Raven Press 173 206
30. G. Kelly Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2 Nat. Med. 8 2002 1098 1104
31. J.M. Timms Target cells of Epstein-Barr-virus (EBV)-positive post-transplant lymphoproliferative disease: similarities to EBV-positive Hodgkin's lymphoma Lancet 361 2003 217 223
32. A. Bell, and A.B. Rickinson Epstein-Barr virus, the TCL-1 oncogene and Burkitt's lymphoma Trends Microbiol. 11 2003 495 497
33. H.H. Niller EBV-associated neoplasms: alternative pathogenetic pathways Med. Hypotheses 62 2004 387 391
34. T. Goossens Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease Proc. Natl. Acad. Sci. U. S. A. 95 1998 2463 2468
35. H. Martinez-Valdez Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2 J. Exp. Med. 183 1996 971 977
36. S. Lebecque Germinal center founder cells display propensity for apoptosis before onset of somatic mutation J. Exp. Med. 185 1997 563 571
37. U. Klein Transcriptional analysis of the B cell germinal center reaction Proc. Natl. Acad. Sci. U. S. A. 100 2003 2639 2644
38. G. Niedobitek Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue Blood 79 1992 2520 2526
39. J. Kurth EBV-infected B cells in infectious mononucleosis: viral strategies for spreading in the B cell compartment and establishing latency Immunity 13 2000 485 495
40. J.G. Howe, and M.D. Shu Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements Cell 57 1989 825 834
41. E. Kilger Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor EMBO J. 17 1998 1700 1709
42. R.G. Caldwell Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals Immunity 9 1998 405 411
43. G. Kennedy Epstein-Barr virus provides a survival factor to Burkitt's lymphomas Proc. Natl. Acad. Sci. U. S. A. 100 2003 14269 14274
44. J.P. Van Straaten, and T.H. Rabbitts The c-myc protein is associated with the nuclear matrix through specific metal interaction Oncogene Res. 1 1987 221 228
45. B. Amati Function of the c-Myc oncoprotein in chromatin remodeling and transcription Biochim. Biophys. Acta 1471 2001 M135 M145
46. Z. Li A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells Proc. Natl. Acad. Sci. U. S. A. 100 2003 8164 8169
47. B.W. Cherney A role for deregulated c-Myc expression in apoptosis of Epstein-Barr virus-immortalized B cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 12967 12971
48. Q. Li, and C.V. Dang c-Myc overexpression uncouples DNA replication from mitosis Mol. Cell. Biol. 19 1999 5339 5351
49. A. Pajic Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch J. Gen. Virol. 82 2001 3051 3055
50. M.S. Staege MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells Proc. Natl. Acad. Sci. U. S. A. 99 2002 4550 4555
51. K. Pokrovskaja CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines Int. J. Cancer 99 2002 705 712
52. K. Machida Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes Proc. Natl. Acad. Sci. U. S. A. 101 2004 4262 4267